Medicamen promoter converts warrants, lifting stake to 42.57%
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 1.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Medicamen allotted 500,000 equity shares to promoter Shivalik Rasayan on October 23, 2026, following conversion of fully convertible warrants issued preferentially. Shivalik's stake rose from 40.46% to 42.57%, a gain of 3.56 percentage points. Share count increased to 14,062,815 and paid-up capital to Rs 140.63 million.
Promoter voting power increased, while other shareholders were diluted by the enlarged share count. The promoter stake remains below 50% at 42.57%.